Connection

Antonio Giordano to Bevacizumab

Back to Details
This is a "connection" page, showing publications Antonio Giordano has written about Bevacizumab.
Antonio Giordano
Connection Strength
0.063
Bevacizumab
  1. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis. Lancet Oncol. 2019 10; 20(10):1360-1369.
    View in: PubMed
    Score: 0.040
  2. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res. 2011 Jun 15; 13(3):R67.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.